Skip to content

China International Capital Corporation

Recent events

Recent events tied to this brand in public sources.

Back to profile19 entries

  1. 2026

    CICC completes absorption merger of Dongxing Securities and Cinda Securities

    China International Capital Corporation Limited (CICC) said it completed the share-swap absorption merger of Dongxing Securities and Cinda Securities. Their existing customers and businesses, including investment banking projects, were transferred to CICC, which will continue to perform the agreements signed by the two firms.

  2. 2026

    Ant Ling launches finance-enhanced model Ling-3.0-flash-Fin

    Ant Ling launched the finance-enhanced model Ling-3.0-flash-Fin, retaining the Ling-3.0-flash architecture with 124B total parameters and 5.1B activated parameters, and said the model weights will be open-sourced next week. The model was tested on financial agent benchmarks including FinFIRST, co-built by Ant Group and CICC, and will be offered free via OpenRouter for one month.

  3. 2026

    CICC, Dongxing Securities and Xinda Securities disclose reply to SSE inquiry on absorption merger integration plan

    On the evening of August 18, 2026, CICC, Dongxing Securities and Xinda Securities simultaneously disclosed announcements replying to the Shanghai Stock Exchange inquiry regarding CICC's absorption merger of Dongxing Securities and Xinda Securities. The reply sets out an operating transition period for phased client and business migration, legal entity switching and system integration, integration of institutional and wealth management businesses into CICC's corresponding departments, and succession of all employee labor contracts under the principle that staff follow the business. Share swap prices were slightly adjusted to 16.05 yuan per share for Dongxing Securities and 19.11 yuan per share for Xinda Securities due to 2025 cash dividend ex-rights and ex-dividend effects, while dissenting shareholders may exercise cash options at 13.04 yuan and 17.75 yuan per share respectively.

  4. 2021

    CICC wins 2021 All-Asia Executive Team awards

    CICC was named among the Most Honored Companies in the 2021 All-Asia Executive Team awards and won the Best ESG award for the third consecutive year. It also received prizes in other categories, including Best CEO, Best CFO, Best IR Professional and Best IR Program.

  5. 2021

    Syngenta Group begins IPO counseling for planned STAR Market listing

    Syngenta Group disclosed an IPO counseling filing with the Shanghai Securities Regulatory Bureau and began listing counseling, with a planned listing on the STAR Market.

  6. 2021

    Clover Biopharmaceuticals files for Hong Kong IPO

    Clover Biopharmaceuticals filed for an initial public offering in Hong Kong. The company did not disclose the offering size; Goldman Sachs and CICC will sponsor the listing.

  7. 2021

    CICC announces 2020 annual results

    China International Capital Corporation Limited (CICC) announced its annual results for the year ended December 31, 2020, reporting total revenue and other income of RMB32.40 billion and net profit of RMB7.21 billion.

  8. 2021

    Huabao Securities begins IPO counseling

    Huabao Securities entered the IPO counseling stage, with China International Capital Corporation serving as its counseling institution.

  9. 2020

    Ant Group enters IPO counseling period

    Ant Group formally entered the IPO counseling period, with China International Capital Corporation and China Securities Construction Investment appointed as counseling institutions for its A-share listing.

  10. 2020

    SPDB signs cooperation agreements with Lingang New Area enterprises

    Shanghai Pudong Development Bank signed comprehensive cooperation agreements with Horizon, CICC's Shanghai Free Trade Zone branch, and OTT PAY, described as important partner enterprises in the new area.

  11. 2020

    Hong Kong SFC publicly criticizes CICCFT and CICC

    Hong Kong’s Securities and Futures Commission publicly criticized CICC Financial Trading Limited and China International Capital Corporation Limited for violating the Takeovers Code by failing to disclose securities transactions in a timely manner. The companies acknowledged the non-compliance and agreed to disciplinary action.

  12. 2020

    CICC and Tencent establish Jinteng Technology

    CICC and Tencent Digital (Shenzhen), a wholly owned subsidiary indirectly held by Tencent, jointly established Jinteng Technology Information (Shenzhen) Co., Ltd. on June 24, 2020. CICC holds a 51% stake. The company was intended to provide technology-platform development and digital-operation support for CICC’s wealth-management and retail-brokerage businesses.

  13. 2020

    Xinhua Lian Group and CICC sign cooperation agreement

    Xinhua Lian Group and China International Capital Corporation held a signing ceremony for a cooperation agreement on May 13, 2020.

  14. 2020

    China International Capital Corporation announces planned A-share offering and Shanghai listing

    China International Capital Corporation announced that it planned to apply to issue up to 459 million A-shares and list on the Shanghai Stock Exchange. The company said the proposal had been approved by its board on February 28.

  15. 2020

    CICC announces plan to list shares in mainland China

    China International Capital Corporation announced that it would pursue an A-share listing in mainland China and said it planned to issue up to 459 million A shares, subject to regulatory requirements and other conditions.

  16. 2020

    CICC proposes an A-share issuance and listing

    CICC announced that it plans to apply to issue A shares and list on the Shanghai Stock Exchange, proposing a public offering of no more than 459 million shares, subject to regulatory requirements and shareholder approval.

  17. 2019

    CICC and Shanghai Pudong Development Bank sign strategic cooperation agreement

    CICC and Shanghai Pudong Development Bank signed a comprehensive strategic cooperation agreement on November 28, covering areas including brokerage, asset management, financing, investment banking and international business.

  18. 2019

    AstraZeneca and CICC announce a China healthcare investment fund

    AstraZeneca said it was launching a fund with China International Capital Corporation to invest $1 billion in China's healthcare sector. The agreement was to be signed at the China International Import Expo.

  19. 2019

    中金公司 signs strategic cooperation agreement with Liaoning provincial government

    中金公司 signed a strategic cooperation agreement with the Liaoning provincial government. The company is to support mixed-ownership reform of state-owned enterprises in Liaoning and provide financing and industrial-fund services.